Insilico Biotechnology expands its patent portfolio with a biotechnological method for acrylic acid production

27 September 2016

Insilico Biotechnology, a leading provider of predictive solutions for knowledge-based biotechnology, has been granted a patent for a new method for the biotechnological production of acrylic acid. The method enables this key raw material to be produced cost-effectively and sustainably. The compound is used for producing superabsorbents such as nappies from renewable materials. read more

Corynebacterium glutamicum in the fast lane: accelerated bioproduction with a popular amino acid producer

25 July 2016

The soil bacterium Corynebacterium glutamicum has already had a successful career in the biotechnology sector as a producer of amino acids. However, its industrial potential will now be expanded even further in a BMBF-funded research project being carried out by Insilico Biotechnology AG in cooperation with partners from academia. read more

Biosimilars: Together Alvotech and Insilico Biotechnology are Forging the Future

27 November 2015

Expiring patents of biopharmaceuticals are paving the market for biosimilars. The Icelandic based manufacturer Alvotech is currently cooperating with Insilico Biotechnology AG from Stuttgart, in order to market high-quality antibodies as biosimilars. read more

Insilico Banks on Growth and Innovation – Capital Increase Completed

10 July 2015

Insilico Biotechnology AG ensures innovation capacity and growth with an increase of capital and with moving into expanded office premises within Stuttgart Engineering Park. read more

Pharmacelsus and Insilico Biotechnology Join Forces to Deliver Combined Solutions in Preclinical Drug Development

10 February 2014

Pharmacelsus, Germany’s market-leading preclinical CRO and Insilico Biotechnology, leading provider of innovative solutions around the simulation of biological processes, combine their expertise in preclinical characterization of drug-candidates. read more